SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

Share Price is delayed by 15 minutes
Get Live Data
16.00    0.00 (0.00%)
Bid:
15.00
Ask:
17.00
Spread: 2.00 (13.333%)
Market Cap: £17.55m
TEAM Live PriceLast checked at - London Stock Exchange

Intraday Team Share Chart

Convertible Loan Note

7 May 2024 15:30

RNS Number : 4762N
Team PLC
07 May 2024
Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF EU REGULATION NO. 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Β 

7 May 2024

Β 

Β 

("TEAM", the "Company" or the "Group")

Β 

Convertible Loan Note

TEAM plcΒ (AIM:Β TEAM),Β the wealth, asset management and complementary financial services group, is pleased to announce that it is raising Β£500,000 (gross) through the subscription for unsecured convertible loan notes at par value by Growth Financial Services, a Harwood Capital Management LLP subsidiary (the "Noteholder").

The net proceeds of the issue of the Convertible Loan Notes will provide funding for the Company for working capital purposes.

Details of the Convertible Loan Notes:

Β· The principal amount of the Convertible Loan Notes is Β£500,000

Β· The Convertible Loan Notes are unsecured

Β· The Convertible Loan Notes have a term of 5 years, due 7 May 2029 (the "Maturity Date"), but may be redeemed early at the option of the Company after an initial period of at least 12 months

Β· Until the Convertible Loan Notes are repaid by the Company, or converted, interest will accrue (as payment-in-kind) at:

oΒ  1% for the first three years from issue, and then

oΒ  SONIA plus 2% (capped at a maximum of 7.5%) thereafter

Β· The Convertible Loan Notes are convertible into the Company's ordinary shares ("Shares") at any time during the period prior to the third anniversary of issue, at the election of the Noteholder, at 25 pence per Share (the "Conversion Price")

Β· On the Maturity Date, any Convertible Loan Notes that have not been converted into Ordinary Shares must be repaid by the Company at par, together with any accrued interest

Β· In the event of a change of control at any time prior to the third anniversary, the Noteholder shall have the right to convert all (but not part only) of the Convertible Loan Notes outstanding at the Conversion Price or, if lower, the actual price per Share at which the change of control event occurs

Β· The Convertible Loan Notes will not be listed on any market or stock exchange but can be transferred by a noteholder

Β 

Β For further information, please contact:

Β 

Enquiries to

TEAM plc

Mark Clubb, Executive Chair

Matthew Moore, CFO and COO

Β 

+44 1534 877 210

Strand HansonΒ (Nominated Adviser to TEAM)

Richard Johnson, James Spinney, David Asquith

+44 207 409 3494

Oberon Capital (Broker to TEAM)

Michael Seabrook, Adam Pollock, Jessica Cave

+44 20 3179 0500

Novella CommunicationsΒ (Financial Public Relations)

Tim Robertson, Claire de Groot, Safia Colebrook

+44 20 3151 7008

Hannam & PartnersΒ (Financial Adviser to TEAM)

Giles Fitzpatrick, Richard Clarke

+44 20 7907 8500

www.teamplc.co.uk

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEALSXEFKLEFA
Date   Source Headline
4th Dec 20255:45 pmRNSForm 8.3 - TEAM PLC
4th Dec 20254:49 pmRNSForm 8.3 - TEAM Plc
4th Dec 202511:42 amGNWForm 8.5 (EPT/RI) - Team Plc
1st Dec 202510:40 amGNWForm 8.5 (EPT/RI) - Team Plc
28th Nov 20252:45 pmRNSForm 8.3 - Team PLC
28th Nov 20252:20 pmRNSForm 8.3 - Team plc
28th Nov 202510:13 amGNWForm 8.5 (EPT/RI) - Team Plc
27th Nov 20255:20 pmRNSHolding(s) in Company
27th Nov 202511:52 amGNWForm 8.5 (EPT/RI) - Team Plc
27th Nov 20257:30 amRNSRECOMMENDED ACQUISITION OF W.H. IRELAND GROUP PLC
27th Nov 20257:26 amRNSForm 8.3 - TEAM Plc
26th Nov 20257:04 amRNSForm 8.3 - Team plc
21st Nov 20255:00 pmRNSForm 8 Opening Position Disclosure
21st Nov 20253:45 pmRNSHolding(s) in Company
21st Nov 202511:50 amGNWForm 8.5 (EPT/RI) - Team Plc
17th Nov 202510:28 amGNWForm 8.5 (EPT/RI) - Team Plc
14th Nov 20253:13 pmRNSForm 8.3 - Team Plc
14th Nov 202511:26 amGNWForm 8.5 (EPT/RI) - Team Plc
14th Nov 20259:26 amGNWForm 8.3 - [TEAM PLC - Opening Disclosure - 13 11 2025] - (CGAML)
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:59 amRNSReplacement- Statement regarding media speculation
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20258:15 amRNSStatement regarding recent media speculation
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
8th Sep 20256:00 pmRNSHolding(s) in Company
3rd Sep 20253:42 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNS-RDirectorsTalk Interview
6th Aug 20257:00 amRNSLaunch of UCITS Fund
16th Jul 20252:35 pmRNSChange of Registered Office Address
30th Jun 20257:06 amRNSHalf-year Report
19th Jun 202512:45 pmRNSHolding(s) in Company
25th Apr 20256:16 pmRNSHolding(s) in Company
25th Apr 20257:00 amRNSResult of AGM
8th Apr 20252:24 pmRNSEquity Subscription
7th Apr 20254:11 pmRNSHolding(s) in Company
3rd Apr 202512:30 pmRNSUpdated Notice of AGM
27th Mar 20256:28 pmRNSDirector’s Dealing
27th Mar 20252:47 pmRNSDirector/PDMR Shareholding
25th Mar 20254:30 pmRNSDirector/PDMR Shareholding
24th Mar 20254:40 pmRNSDirector's Dealing - Replacement
24th Mar 202511:21 amRNSDirector's Dealing
21st Mar 20252:15 pmRNSEquity Subscription
20th Mar 20257:00 amRNSProposed Board Changes and Notice of AGM
4th Mar 20258:15 amRNSDirector/PDMR Shareholding
3rd Mar 20257:10 amRNSFund Raise and Issue of Equity
3rd Mar 20257:00 amRNSFinal Results
29th Jan 20254:30 pmRNSTotal Voting Rights Update
24th Jan 20253:25 pmRNSResult of EGM
7th Jan 20251:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.